Skin Vaccination Summit 2015

2-4 September 2015, University of LausanneCHUV, Lausanne, Switzerland

  • Increase font size
  • Default font size
  • Decrease font size

Day One

Final Conference Programme | Wednesday 2nd September 2015

08.30-10.30
Registration/Coffee/Poster-Setup

SESSION 1:
OPENING PLENARY SESSION

Moderator: Bruce Weniger (Chiang Mai University, Chiang Mai, Thailand)

‘Introductory remarks on the event of the 3rd SKIN VACCINATION SUMMIT’
Bruce Weniger (Chiang Mai University, Chiang Mai, Thailand)

10.30-11.00
‘From idea to impact: The myriad challenges of technology development for global public health’
Darin Zehrung (PATH, Seattle, Washington, USA)

11.00-11.30
‘From muscles to skin: More variables to consider when vaccinating?’
Nathalie Garcon (BIOASTER, Lyon, France)

11.30-12.00
‘Innate lymphoid cells: New players on the block regulating skin immune responses’
Marcel B.M. Teunissen (University of Amsterdam, The Netherlands)

12.00-12.30
‘Omics analysis of skin vaccination’
Behazine Combadiere (Universite Pierre and Marie Curie, Paris, France)

12.30-14.00
Lunch Break & Posters

SESSION 2:
DELIVERY TECHNOLOGIES

Moderators: Derek O’Hagan (Novartis Vaccines, Cambridge, Massachusetts, USA) and Nathalie Garcon (BIOASTER, Lyon, France)

14.00-14.30
‘Delivering DNA to the skin for intra-epidermal vaccination and immunotherapy’
James Birchall (University of Cardiff, Cardiff, Wales, UK)

14.30-14.50
‘The use of dissolving polymeric MN arrays in the targeted delivery of nanoencapsulated antigen to skin dendritic cells’
M.T.C. McCrudden, M. Zaric, A. Kissenpfennig and R.F. Donnelly (Queen’s University of Belfast, Belfast, Northern Ireland, UK)

14.50-15.10
‘Exploring the mechanisms behind intradermal electroporation’
Katherine Schultheis, Laurent Humeau and Niranjan Sardesai (INOVIO Inc., Plymouth Meeting, Pennsylvania, USA)

15.10-15.30
‘Cutaneous immunogen delivery via a novel laser microporation platform’
Yoan Machado 1, Melissa Mayr 1, Veronika Höpflinger 1, Doris Bach 1, Michael Hessenberger 1, Sophie Kitzmueller 1, Elmira Lechat 2, Josef Thalhamer 1, Sandra Scheiblhofer 1 and Richard Weiss 1 (1: Department of Molecular Biology, Division of Allergy and Immunology, University of Salzburg, Austria / 2: Pantec Biosolutions AG, Ruggell, Liechtenstein)

15.30-16.00
Tea Break & Posters

SESSION 3:
IMMUNE RESPONSES/CLINICAL TRIALS 1

Moderators: Richard W. Compans (Emory University, Atlanta, Georgia, USA) and John Clements (Tulane University, New Orleans, Louisiana, USA)

16.00-16.30
‘Mucosal immune responses following parenteral immunization: Re-evaluating the paradigm for induction of mucosal immunity’
John Clements (Tulane University, New Orleans, Louisiana, USA)

16.30-17.00
‘A single dose of cutaneously delivered unadjuvanted tetanus toxoid confers complete protection in pregnant mice and their infants’
Ioanna Skountzou, E. Stein Esser, Andrey A. Romanyuk, Elena V. Vassilieva, Mark R. Prausnitz and Richard W. Compans (Emory University / Georgia Institute of Technology, Atlanta, Georgia, USA)

17.00-17.20
‘Mucosal immunity induced by skin based vaccination with ImmuPatch dissolvable microneedle patches in mice’
O. Flynn, E. Allen, K. Dillane, A. Crean and A. Moore (University College Cork, Ireland) and Elizabeth Norton (Tulane University, New Orleans, Louisiana, USA)

17.20-17.40
‘A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacilli Calmette-Guerin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe’
Hennie D. Geldenhuys, Helen Mearns, Jennifer Foster, Eugene Saxon, Ben Kagina, Laura Saganic, Courtney Jarrahian, Michele D. Tameris, One B. Dintwe, Michele Van Rooyen, Kany-Kany A. Luabeya, Gregory Hussey, Thomas J. Scriba, Mark Hatherill and Darin Zehrung (SATVI, University of Cape Town, Cape Town, South Africa)

17.40-18.00
‘The safety and immunogenicity of inactivated poliovirus vaccine when given concomitantly with a measles and rubella combined vaccine and when given by different administration routes: A phase 4, randomised, non-inferiority trial’
E. Clarke, Y. Saidu, A. Bashorun, A. Umesi, M. Hydara-Badjie, J. Adetifa, M. Ngozi, I. Adigweme, P. Cham, E. Roberts, J. Mueller, V. Thomas-Njie, D. Jeffries and B. Kampmann (MRC Unit, The Gambia, PO Box 273, Banjul, The Gambia)

18.00-18.20
‘Investigating practical and acceptability issues related to needle-free jet injection devices for the delivery of IPV: A nested study within a randomised trial in The Gambia’
J. Bibby, C. Jarrahian, M. Royals, B. Kampmann and E. Clarke (MRC Unit, The Gambia, PO Box 273, Banjul, The Gambia)

18.20-19.20
SVS 2015 Drinks Reception & Poster Session

 

SVS 2015 Delegates

Login details will be supplied after you have registered for the event.


SVS 2015 Sponsors

  • Corium
  • UniVac
  • ONdrugDELIVERY
  • 3M
  • IDRI
  • Bioject
  • NatureGeneTherapy
  • Debiotech
  • Becton Dickinson
  • West
  • Novartis Vaccines
  • Sanofi Pasteur
  • Swiss Vaccine Research Institute
  • DNAvaccine.com
  • Inovio Pharmaceuticals
  • PATH
  • Star Syringe
  • NanoPass
  • Aldevron

SVS 2015 Downloads

SVS 2015 Leaflet

SVS 2015 Mailing List

Name
E-mail Address
What is 3+2-1?